Xinjun Lu
Overview
Explore the profile of Xinjun Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu X, Zhu Q, Cai J, Yang Z, Gu G, Pang L, et al.
Cancer Immunol Immunother
. 2024 Nov;
74(1):18.
PMID: 39527136
Immune checkpoint inhibitor (ICI)-based immunotherapy has emerged as the most promising strategy for hepatocellular carcinoma (HCC) downstaging prior to liver transplantation (LT). However, further evidence is required to assess the...
2.
Lu X, Zhang Y, Xue J, Evert M, Calvisi D, Chen X, et al.
Toxicol Sci
. 2024 Sep;
203(1):41-51.
PMID: 39316419
Mitotic arrest-deficient 2 like 1 (MAD2L1) is a component of the mitotic spindle assembly checkpoint implicated in cancer cell proliferation and tumorigenesis. The functional role of MAD2L1 in hepatocellular carcinoma...
3.
Deng S, Lu X, Wang X, Liang B, Xu H, Yang D, et al.
Cell Death Dis
. 2024 Jun;
15(6):441.
PMID: 38909034
TBX3 behaves as a tumor suppressor or oncoprotein across cancer. However, TBX3 function remains undetermined in intrahepatic cholangiocarcinoma (iCCA), a deadly primary liver malignancy with few systemic treatment options. This...
4.
Guo Z, Liu Y, Ling Q, Xu L, Wang T, Zhu J, et al.
Am J Transplant
. 2024 Apr;
24(10):1837-1856.
PMID: 38642712
Immune checkpoint inhibitors (ICIs) as a downstaging or bridging therapy for liver transplantation (LT) in hepatocellular carcinoma patients are rapidly increasing. However, the evidence about the feasibility and safety of...
5.
Zhang H, Zhu K, Zhang R, Guo Y, Wang J, Liu C, et al.
Hepatology
. 2024 Feb;
80(1):69-86.
PMID: 38377465
Background And Aims: Lymph node metastasis is a significant risk factor for patients with cholangiocarcinoma, but the mechanisms underlying cholangiocarcinoma colonization in the lymph node microenvironment remain unclear. We aimed...
6.
Wei M, Cong Y, Lei J, Du R, Yang M, Lu X, et al.
Chem Biol Interact
. 2023 Oct;
386:110782.
PMID: 37884181
Fine particulate matter (PM) has attracted increasing attention due to its health-threatening effects. Although numerous studies have investigated the impact of PM on lung injuries, the specific mechanisms underlying the...
7.
Wang X, Zhang J, Lu X, Bai Y, Wang G
J Genet Genomics
. 2023 Oct;
51(5):467-478.
PMID: 37879496
Plants serve as rich repositories of diverse chemical compounds collectively referred to as specialized metabolites. These compounds are of importance for adaptive processes, including interactions with various microbes both beneficial...
8.
Chen Y, Liu Y, Chen S, Zhang L, Rao J, Lu X, et al.
Front Immunol
. 2023 Jun;
14:1180184.
PMID: 37334366
Primary liver cancer (PLC) is one type of cancer with high incidence rate and high mortality rate in the worldwide. Systemic therapy is the major treatment for PLC, including surgical...
9.
Lu X, Green B, Xie C, Liu C, Chen X
JHEP Rep
. 2023 May;
5(7):100723.
PMID: 37229173
Cholangiocarcinoma (CCA) is a rare primary liver cancer associated with high mortality and few systemic treatment options. The behaviour of the immune system has come into focus as a potential...
10.
Zhang L, Liao W, Chen S, Chen Y, Cheng P, Lu X, et al.
Front Oncol
. 2023 Apr;
13:1146477.
PMID: 37077835
Three-dimensional cell culture technology (3DCC) sits between two-dimensional cell culture (2DCC) and animal models and is widely used in oncology research. Compared to 2DCC, 3DCC allows cells to grow in...